21 August 1992
28 March 1988
COMMERCIAL ITEM DESCRIPTION
ACETOHYDROXAMIC ACID TABLETS
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Acetohydroxamic Acid Tablets.
Shall contain 250 mg of Acetohydroxamic Acid per tablet, within the applicable assay limits, when assayed by a suitable, accurate and reproducible assay method.
All ingredients shall be of a pharmaceutical grade.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredients (s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the direction of the supplier.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle, containing 100 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business